VASCULAR SMOOTH MUSCLE-SPECIFIC ELASTIN DELETION IS A NOVEL GENETIC MODEL FOR NEOINTIMAL HYPERPLASIA

被引:1
|
作者
Lin, Chien-Jung [1 ]
Staiculescu, Marius C. [1 ]
Wagenseil, Jessica [1 ]
Mecham, Robert P. [1 ]
机构
[1] Washington Univ, St Louis, MO USA
关键词
D O I
10.1016/S0735-1097(19)32641-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
903-06
引用
收藏
页码:2035 / 2035
页数:1
相关论文
共 50 条
  • [41] Bladder function in mice with inducible smooth muscle-specific deletion of the manganese superoxide dismutase gene
    Liu, Guiming
    Elrashidy, Rania A.
    Xiao, Nan
    Kavran, Michael
    Huang, Yexiang
    Tao, Mingfang
    Powell, C. Thomas
    Kim, Edward
    Sadeghi, Ghazal
    Mohamed, Hoda E.
    Daneshgari, Firouz
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2015, 309 (03): : C169 - C178
  • [42] Smooth Muscle-Specific Deletion of Cullin-3 Causes Severe Early Onset Hypertension
    Agbor, Larry N.
    Nair, Anand R.
    Wu, Jing
    Davis, Deborah R.
    Keen, Henry L.
    Quelle, Frederick W.
    McCormick, James A.
    Singer, Jeffrey D.
    Sigmund, Curt D.
    FASEB JOURNAL, 2017, 31
  • [43] Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia
    Ahn, JD
    Morishita, R
    Kaneda, Y
    Kim, HS
    Chang, YC
    Lee, KU
    Park, JY
    Lee, HW
    Kim, YH
    Lee, IK
    GENE THERAPY, 2002, 9 (24) : 1682 - 1692
  • [44] Smooth Muscle-specific Deletion of MURC/Cavin-4 Alleviates Pulmonary Arterial Hypertension
    Nakanishi, Naohiko
    Ogata, Takehiro
    Miyagawa, Kotaro
    Hamaoka, Tetsuro
    Maruyama, Naoki
    Kasahara, Takeru
    Ueyama, Tomomi
    CIRCULATION, 2014, 130
  • [45] Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia
    J D Ahn
    R Morishita
    Y Kaneda
    H S Kim
    Y-C Chang
    K-U Lee
    J-Y Park
    H W Lee
    Y-H Kim
    I-K Lee
    Gene Therapy, 2002, 9 : 1682 - 1692
  • [46] A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injury
    Takayanagi, Takehiko
    Eguchi, Akito
    Takaguri, Akira
    Hinoki, Akinari
    Bourne, Allison M.
    Elliott, Katherine J.
    Hurlin, Peter J.
    Eguchi, Satoru
    ATHEROSCLEROSIS, 2013, 228 (01) : 90 - 93
  • [47] Vascular remodeling in response to carotid ligation in mice with a smooth muscle-specific deletion of cGMP-dependent protein kinase type 1
    Lukowski, R
    Weinmeister, P
    Feil, S
    Gotthardt, M
    Herz, J
    Massberg, S
    Hofmann, F
    Feil, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R52 - R52
  • [48] Vascular Smooth Muscle-Specific EP4 Receptor Deletion in Mice Exacerbates Angiotensin II-Induced Renal Injury
    Thibodeau, Jean-Francois
    Holterman, Chet E.
    He, Ying
    Carter, Anthony
    Cron, Gregory O.
    Boisvert, Naomi C.
    Abd-Elrahman, Khaled S.
    Hsu, Karolynn J.
    Ferguson, Stephen S. G.
    Kennedy, Christopher R. J.
    ANTIOXIDANTS & REDOX SIGNALING, 2016, 25 (12) : 642 - 656
  • [49] Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: A novel target for the prevention of neointimal hyperplasia
    Kotha, Jayaprakash
    Zhang, Chunxiang
    Longhurst, Celia M.
    Lu, Yi
    Jacobs, Jonathan
    Cheng, Yunhui
    Jennings, Lisa K.
    ATHEROSCLEROSIS, 2009, 203 (02) : 377 - 386
  • [50] Inhibition of Vascular Calcification in Smooth Muscle-Specific Runx2 Kockout Mice
    Sun, Yong
    Byon, Chang H.
    Yuan, Kaiyu
    Mao, Xia
    Chen, Jianfeng
    Chen, Yabing
    CIRCULATION, 2011, 124 (21)